| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/30/2010 | CN101756911A Novel sodium ozagrel preparation and preparation method thereof |
| 06/30/2010 | CN101756910A Lung targeting ceftiofur microsphere and preparation method |
| 06/30/2010 | CN101756909A Lung-targeting ceftiofur microsphere and preparation method thereof |
| 06/30/2010 | CN101756907A Oral solid preparation containing polyene phosphatidyl choline and preparation method thereof |
| 06/30/2010 | CN101756906A Pharmaceutical composition of cefcapene pivoxil hydrochloride granules and preparation method thereof |
| 06/30/2010 | CN101756905A Preparation method for supercritical anti-solvent of water-soluble nano glycyrrhizic acid powder |
| 06/30/2010 | CN101756904A Preparation process for chitosan microsphere |
| 06/30/2010 | CN101756902A Clonidine multivesicular liposome and preparation method thereof |
| 06/30/2010 | CN101756901A Hydrofluoroalkane aerosol containing lidocaine |
| 06/30/2010 | CN101756900A Elemene micro-emulsion |
| 06/30/2010 | CN101756899A Valnemulin nano-emulsion antibacterial medicine preparation |
| 06/30/2010 | CN101756898A Lansoprazole sodium suspension preparation for injection and new application thereof |
| 06/30/2010 | CN101756897A Clindamycin hydrochloride injection and preparation method thereof |
| 06/30/2010 | CN101756896A Kudzu-vine root daidzein-7, 4'-dioxo acetic acid compound transfusion formula and preparation method thereof |
| 06/30/2010 | CN101756895A Polyene phosphatidyl choline intravenous preparation and preparation method thereof |
| 06/30/2010 | CN101756894A Method for filtering sodium ferulate high-capacity injection |
| 06/30/2010 | CN101756893A Inflammation diminishing and fluid supplementing medicine for livestock |
| 06/30/2010 | CN101756892A Xylitol injection and preparation method thereof |
| 06/30/2010 | CN101756891A Cladribine preparation administrated by injection and preparation method thereof |
| 06/30/2010 | CN101756890A Parenteral preparation containing active entecavir and preparation method thereof |
| 06/30/2010 | CN101756889A Lamivudine ester injection and preparation method thereof |
| 06/30/2010 | CN101756888A Temperature-controlled sustained-release injection containing isoliquiritigenin and preparation method thereof |
| 06/30/2010 | CN101756886A Imiquimod micro emulsion gels for local skin and preparation method thereof |
| 06/30/2010 | CN101756885A Displeased taste and oral liquid preparation with reduced odor |
| 06/30/2010 | CN101756761A Heating patch with coupling agent and preparation process thereof |
| 06/30/2010 | CN101756582A Medicinal healthcare pillow with treatment effect on cervical spondylosis |
| 06/30/2010 | CN101756580A Spirit-quieting and brain-invigorating medical care pillow |
| 06/30/2010 | CN101544661B Cefobutazine sodium compound and pharmaceutical composition made therefrom |
| 06/30/2010 | CN101332188B Method for preparing powder injection using attritioning technique and prepared products |
| 06/30/2010 | CN101322848B Composition for gastroscopy and preparation thereof |
| 06/30/2010 | CN101317852B Powder injection of compound glycyrrhizic acid glycosides and preparation method thereof |
| 06/30/2010 | CN101292987B Pharmaceutical combination |
| 06/30/2010 | CN101283999B Medicinal composition mainly for curing cardiovascular and cerebrovascular diseases and preparation method thereof |
| 06/30/2010 | CN101280048B Transparent aquagel having antibacterial action and preparation thereof |
| 06/30/2010 | CN101265264B Method for producing high-purity mezlocillin sodium and powder injection thereof |
| 06/30/2010 | CN101244045B Zero level drug administration oral controlled-release tablet and preparation thereof |
| 06/30/2010 | CN101234122B New purpose of polylysine |
| 06/30/2010 | CN101210044B Polypeptide and application thereof |
| 06/30/2010 | CN101095669B Osthole phospholipid complexes and method for preparing the same and application thereof |
| 06/30/2010 | CN101085343B SOD health care composition |
| 06/30/2010 | CN101084874B Method for preparing water soluble hypocrellin silica nanometer particle and its application in preparing venous injection |
| 06/30/2010 | CN101077343B Dexibuprofen granule and preparation method thereof |
| 06/30/2010 | CN101024604B Novel dihydrochalcone compound separated and purified from drgon blood and preparation method thereof |
| 06/29/2010 | USRE41408 pharmacokinetics; opioid addiction |
| 06/29/2010 | US7745694 Methods and compositions for synthesis of long chain polyunsaturated fatty acids in plants |
| 06/29/2010 | US7745665 Substituted phenethylamines |
| 06/29/2010 | US7745663 mitogen-activated protein kinase inhibitors such as 3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-N-(2-hydroxy-ethoxy)-5(2-hydroxy-ethoxymethyl)-benzamide, used to treat proliferative diseases, for example, cancers, psoriasis, restenosis, autoimmune diseases and atherosclerosis |
| 06/29/2010 | US7745662 Polycationic compounds and uses thereof |
| 06/29/2010 | US7745656 Compounds with stabilized S-nitrosyl group and a free alcohol or a free thiol; nitric oxide (NO) releasing; bacteristats; reacting a polythiol or a thioalcohol with a nitrosylating agent (S-Nitrosyl-N-acetyl-D,L-penicillamine (SNAP) and and tert-butylnitrite); |
| 06/29/2010 | US7745651 liposomes; nucleic acid lipid particles; gene therapy; improved membrane fluidity |
| 06/29/2010 | US7745650 9,10-α,α-OH-taxane analogs and methods for production thereof |
| 06/29/2010 | US7745644 Antibiotic compounds |
| 06/29/2010 | US7745641 such as 4-Methanesulfonyloxy-5-methoxy-7-[1H-5-(methylaminomethyl)indol-2-yl]isoindolinone, having an antitumor activity |
| 06/29/2010 | US7745640 cyanine dyes capable of conjugating with proteins, antibodies, enzymes, nucleosides, oligonucleotides, biotin, haptens, lectins, carotenoids, hormones, neurotransmitters, growth factors, toxins, cells, lipids or polymers, for their detection and quantitation |
| 06/29/2010 | US7745639 Dihydropyrazoles; anticarcinogenic agents can be synergistically combined with one or more active ingredients; side effect reduction |
| 06/29/2010 | US7745637 Peptide deformylase inhibitors |
| 06/29/2010 | US7745630 Triazolyl piperidine arginine vasopressin receptor modulators |
| 06/29/2010 | US7745625 Phosphate prodrugs; treating HIV infection; 1-(phosphomethyl)-3-(2-(4-benzoylpiperazin-1-yl)-1,2-dioxoethyl)-4,7-dimethoxy-1H-pyrrolo(2,3-c)pyridine for example; improved water solubility, bioavailability for oral administration |
| 06/29/2010 | US7745622 Crystalline N-(4-(4-ammoniumthieno[2,3-d]pyrimidin-5-yl)phenyl)-N′-(2-fluoro-5-(trifluoromethyl)phenyl)urea benzenesulfonate |
| 06/29/2010 | US7745621 Long acting bronchodilators for the treatment of respiratory diseases |
| 06/29/2010 | US7745619 alkaloids; anticarcinogenic, antiproliferative agent; inhibitor of cellular mitosis and cell proliferation; binding to tubulin leads to cell cycle arrest in M phase and subsequently to apoptosis; antiallergen, antiinflammatory, antidiabetic, autoimmune diseases; asthma, arthritis, Alzheimer' disease |
| 06/29/2010 | US7745613 Method for preparing peritoneal dialysate |
| 06/29/2010 | US7745609 DNA, RNA or chimeric oligonucleotide that is at least 90% complementary the nucleic acid encoding CD40 antigens, used for inhibiting the expression of CD40 in cells or tissues; antitumor and antiproliferative agents |
| 06/29/2010 | US7745608 Conjugated lipophilic group with a modified nucleotide is used to target disease gene, cells, tissue, for drug delivery to entrance into tumor cells; ribose sugar of nucleotide is replaced with a cyclic carrier which has at least one attached phosphate or phosphorothioate group; antitumor biodrugs |
| 06/29/2010 | US7745606 polynucleotides used for modulating immune responses; immunotherapy |
| 06/29/2010 | US7745581 T-bet compositions and methods of use thereof |
| 06/29/2010 | US7745496 Such as 4-bromobutylnitrate in particular organic solvents such as methylene chloride, trichloromethane, perfluorohexane, tetrachloromethane and perfluoroheptane are stable and are not explosive |
| 06/29/2010 | US7745495 dioxo-bicyclo(3.2.1)octane or bicyclo(2.2.2)nonane or bicyclo(3.3.1)nonane compounds having a 2-difluoromethyl-5-alkoxypropylpyridin-5-ylcarbonyl attachment; chemical intermediates; controlling weeds, in particular in crops of cultivated plants |
| 06/29/2010 | US7745494 Vitamin K for prevention and treatment of skin rash secondary to anti-EGFR therapy |
| 06/29/2010 | US7745493 acamprosate; Parkinson's disease or Huntington's disease |
| 06/29/2010 | US7745492 Carboxamido opioid compounds |
| 06/29/2010 | US7745491 2(R)-2-(4-cyclopropanesulfonylphenyl)-N-(1-methylpyrazol-3-yl)-3-((R)-3-oxocyclopentyl)propionamide, useful in the prophylaxis and treatment of hyperglycemia and diabetes; hypoglycemic and antidiabetic agents |
| 06/29/2010 | US7745489 Potent 2-oxo-amide based compounds; abrogating prostaglandin production; low dosage; spinal cord and central nervous system pain |
| 06/29/2010 | US7745488 Therapy for neutropenia as result of radiation therapy; administering colony stimulating factor |
| 06/29/2010 | US7745487 Method for enhancing physical performance or immune system recovery from intense physical excercise with quercetin-containing compositions |
| 06/29/2010 | US7745486 quercetin, vitamin B3, and vitamin C as only ingredients, specified weight ratio; dietary supplement or a pharmaceutical formulation; free radical induced diseases |
| 06/29/2010 | US7745484 Beta-secretase modulators and methods of use |
| 06/29/2010 | US7745482 crystal structured distrontium salt of 5-[bis(carboxymethyl)amino]-3-carboxymethyl-4-cyano-2-thiophenecarboxylic acid, used in the prevention and treatment of osteoporosis and osteoarthritis |
| 06/29/2010 | US7745481 Methods and compositions for the treatment and prevention of tumors, tumor-related disorders and cachexia |
| 06/29/2010 | US7745480 deuterated (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid, used for the treatment of dyslipidemia and/or hyperlipemia |
| 06/29/2010 | US7745479 1,5-substituted indol-2-yl amide derivatives |
| 06/29/2010 | US7745478 transforming N-benzylphthalimide into N-benzyl-1,1,3,3-tetralkylisoindoline by treatment with a Grignard reagent, then into 1,1,3,3-tetra-alkylisoindoline by hydrogenolysis and oxidation with hydrogen peroxide in the presence of a catalyst to form 1,1,3,3-tetra-alkyl-isoindolin-2-yloxyl |
| 06/29/2010 | US7745477 Heteroaryl and benzyl amide compounds |
| 06/29/2010 | US7745476 1,3,5-trisubstituted 4,5-dihydro-1H-pyrazole derivatives having CB1-antagonistic activity |
| 06/29/2010 | US7745474 tert-butyl 4-{[(4-chlorophenyl)carbonothioyl]amino}-2-(dimethylamino)-1-phenyl-1H-imidazole-5-carboxylate, having a positive allosteric GABA receptor modulator effect, used optionally in combination with a GABA receptor agonist; gastroesophageal reflux; irritable bowel syndrome; dyspepsia |
| 06/29/2010 | US7745473 Indole derivative for alkylating specific base sequence of DNA and alkylating agent and drug containing the derivative |
| 06/29/2010 | US7745472 Dimethylsulfamic Acid 2-bromo-4-{[(4-cyano-phenyl)-[1,2,4]triazol-4-ylamino]methyl}phenyl Ester, used as effective sulfatase and/or aromatase inhibitors, and as modulators of cell cycling and modulators of apoptosis; therapy of breast, prostate, ovarian or endometrial cancer |
| 06/29/2010 | US7745471 reacting 3-bromomethyl-1,2-benzisoxazole and ammonium sulfite in an alcohol and water mixture, to obtain a nonhygroscopic and anhydrous 1,2-benzisoxazole-3-methanesulfonic acid ammonium salt; converting a 1,2-benzisoxazole-3-methanesulfonic acid ester to 1,2-benzisoxazole-3-methanesulfonamide |
| 06/29/2010 | US7745470 N-((1R,2S)-3-(3,5-difluorophenyl)-1-hydroxy-1-((2R,4R)-4-propoxypyrrolidin-2-yl)propan-2-yl)-3-((R)-2-(methoxymethyl)pyrrolidine-1-carbonyl)-5-(oxazol-2-yl)benzamide, used to prevent the accumulation of amyloid protein deposits in the brain; treatment of Alzheimer's disease and Down's Syndrome |
| 06/29/2010 | US7745468 tyrphostin-like compounds that display a significant potency as kinase inhibitors, cause the downregulation of c-myc proto-oncogene and inhibit the growth and survival of cancerous cell lines; antiproliferative agents |
| 06/29/2010 | US7745467 For therapy of pain, inflammation, urological disorders, gynecological disorders, gastrointestinal disorders, respiratory disorders, psoriasis, pruritus, dermal, ocular or mucous irritation, herpes or zona, diabetes, depression |
| 06/29/2010 | US7745466 Magnesium salt of S-omeprazole trihydrate of crystal form and another drug such as NSAID, antibiotic, antacid, alginates or prokinetic agents; gastric acid secretion inhibitor, and is useful as an antiulcer agent |
| 06/29/2010 | US7745465 Antiischemic agents; antiinflammatory agents; antiallergens; autoimmune disease |
| 06/29/2010 | US7745464 heterocyclic compounds that bind to disease-related proteins, used for treating and modulating disorders associated with hyperproliferation, such as cancer |
| 06/29/2010 | US7745463 useful for the treatment of human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS) |
| 06/29/2010 | US7745462 5-[R-2-(1S,2S-2-Cyclohexylcyclopentylamino)-1-hydroxyethyl]-8-hydroxy-1H-quinolin-2-one, useful for treating conditions that are prevented or alleviated by activation of the adrenergic recptors |
| 06/29/2010 | US7745461 Method of treating dry eye disorders |
| 06/29/2010 | US7745460 LFA1 related immune and/or inflammatory disorders; interactions with leukointegrins; such as fused nitrogen heterocyclic secondary amine derivatives |
| 06/29/2010 | US7745459 Quinolizinone compound and use thereof as HIV integrase inhibitor |
| 06/29/2010 | US7745458 (1S,5R)-3-[4-(4-phenyl-2-pyrimidinyl)butyl]-1-[4-(trifluoromethyl)phenyl]-3-azabicyclo[3.1.0]hexane, used for the treatment of drug abuse and dependence, urogenital disorders, as cognition activators and as antipsychotic agents |